BioAxone BioSciences Inc - Company Review
BioAxone BioSciences Inc - Company ReviewSummary
BioAxone BioSciences Inc (BioAxone) is a healthcare company that develops regenerative therapeutic drugs. The company’s pipeline products comprise VX-210, BA-277, BA-434 and BA-1049. It develops products for acute spinal cord injury, cerebral vascular disorders and glaucoma. BioAxone develops products to treat neurotrauma, peripheral nerve damage, and neurovascular disorders. The company conducts research to develop treatments for cerebral cavernous malformation, post injury recovery in chronic spinal cord injury and breakdown of the glial scar that forms subsequent to neurotrauma. It carries out development program to surmount extrinsic barriers to axon regeneration. BioAxone is headquartered in Cambridge, Massachusetts, the US.
This comprehensive company report of BioAxone BioSciences Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.